See the PhD Opportunities section to see if this project is currently open for applications via MIBTP.
Please Note: The main page lists projects via BBSRC Research Theme(s) quoted and then relevant Topic(s).
Engineering E. coli-Derived Extracellular Vesicles for the Modulation of Gut Epithelial-Immune Crosstalk
Secondary Supervisor(s): Dr Doug Browning
University of Registration: Aston University
BBSRC Research Themes:
Project Outline
Engineered bacteria are increasingly being developed as platforms for the delivery of recombinant proteins to mucosal surfaces. Recent studies have shown strains of Escherichia coli (E. coli) can be engineered to express Ara h 2, a major peanut allergen, providing a useful model system for investigating how mode of allergen delivery can influence immune responses at mucosal surfaces.
In parallel, extracellular vesicles (EVs) are emerging as important mediators of host-microbe communication. These nanoscale particles are naturally secreted by bacteria, to transport proteins, lipids and nucleic acids to neighbouring cells. The ability of EVs to package allergens expressed in E. coli and deliver to the intestinal mucosa remains underexplored, with the potential of offering a scalable, cell-free platform for recombinant protein delivery.
Recent advances in the Browning lab have enabled the development of avirulent, intestinally colonising E. coli strains capable of expressing and secreting heterologous proteins. This project will build upon this platform to investigate the expression of Ara h 2, with and without co-expression of Siglec ligand. Subsequently, EVs will be isolated from the E. coli and characterised to determine whether Ara h 2 is incorporated into vesicle cargo and how bacterial engineering influences EV composition.
This project will then compare the biological effects of live engineered E. coli and their secreted EVs in vitro. Using a human intestinal epithelial model co-cultured with immune cells, allergen uptake, intestinal epithelial barrier integrity, and immune responses will be measured. Ultimately to determine whether engineered avirulent E. coli and their EVs can deliver an altered Ara h 2 cargo to influence immune responses. This interdisciplinary project will provide fundamental insight into how engineered microbes and their EVs communicate with the intestinal mucosa and establish a platform for EV-based delivery systems.